Skip to main content

Day: June 3, 2021

Vitamins and Supplements Market Size to Reach USD 196.56 Billion by 2028; High Demand for Innovative & Healthy Products to Aid Growth, reports Fortune Business Insights™

Top companies covered in the vitamins and supplements market are Bayer AG (Leverkusen, Germany), Koninklijke DSM N.V. (Heerlen, Netherlands), Archer Daniels Midland Company (Illinois, U.S.), BASF SE (Ludwigshafen, Germany), Glanbia, Plc (Kilkenny, Ireland), Nuleaf Naturals LLC. (Colorado, U.S), Herbalife Nutrition (California, U.S.), Reckitt Benckiser Group plc (Slough, U.K.), NutraMarks Inc. (California, U.S.), Otsuka Pharmaceutical (Tokyo, Japan), and more players profiled Pune, India, June 03, 2021 (GLOBE NEWSWIRE) — The global vitamins and supplements market size is set to gain impetus from the increasing demand for healthy and innovative products to prevent various symptoms related to coronavirus, such as tiredness, diarrhea, chest pain, and shortness of breath. This information is published by Fortune Business Insights™ in...

Continue reading

Hairy Cell Leukemia Therapeutics Market 2021 | Size, Share, Growth, Trends, Revenue, Competitive Landscape, Forecast Report

Some of the major companies that are present in the global hairy cell leukemia therapeutics market are AstraZeneca, AbbVie Inc., Biogenomics Limited., F. Hoffmann-La Roche Ltd, Astellas Pharma Inc., Janssen Pharmaceuticals, Inc., and Juno Therapeutics. Pune, India, June 03, 2021 (GLOBE NEWSWIRE) — The increasing prevalence of rare cancer is driving the global “hairy cell leukemia therapeutics market”, says Fortune Business Insights in a report, titled “Hairy Cell Leukemia Therapeutics Market Size, Share and Global Trend by Treatment (Chemotherapy, Biological Therapy, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), and Geography Forecast till 2026.” Rising demand for the prevention of second cancer is fostering the growth of the global hairy cell leukemia therapeutics market.Request a Sample...

Continue reading

NewAge Closes Acquisition of Japan-Based Aliven, Inc.

– Expected to add over $20 million in annual revenue and more than $3 million in annual EBITDA to one of NewAge’s core global marketsAliven productsBetter for you products and ingredientsDENVER, June 03, 2021 (GLOBE NEWSWIRE) — NewAge, Inc. (Nasdaq: NBEV), the Colorado-based organic and healthy products company intending to become the world’s leading social selling and distribution company today announced that it acquired the business of Japan-based Aliven, Inc., which is expected to add over $20 million in net revenue and more than $3 million in annual EBITDA to one of NewAge’s largest core global markets. Established 15 years ago, Aliven, Inc. is one of the Japan’s most well-respected companies in the industry and sells a portfolio of differentiated healthy products including Skin Care Products infused...

Continue reading

Conn’s, Inc. Reports First Quarter Fiscal Year 2022 Financial Results

THE WOODLANDS, Texas, June 03, 2021 (GLOBE NEWSWIRE) — Conn’s, Inc. (NASDAQ: CONN) (“Conn’s” or the “Company”), a specialty retailer of furniture and mattresses, home appliances, consumer electronics and home office products, and provider of consumer credit, today announced its financial results for the quarter ended April 30, 2021. “Same store sales exceeded our expectations and increased 19.4% and total sales increased 26.5% as our team capitalized on robust consumer demand and the successful execution of our strategic growth initiatives. Strong first quarter sales were driven by a 70.0% increase in retail sales financed through cash, credit card, and third-party offerings, as our in-house credit underwriting strategy remained conservative during the quarter,” stated Norm Miller, Conn’s Chairman and Chief Executive Officer. “We...

Continue reading

Interim Capital Dividend on Ordinary Shares

Dividend Declaration Seneca Growth Capital VCT Plc  3 June 2021 Seneca Growth Capital VCT Plc Interim Capital Dividend on Ordinary Shares The Directors of Seneca Growth Capital VCT Plc (the “Company”) are pleased to declare an interim capital dividend of 4 pence per Ordinary Share for the year to 31 December 2021, to be paid on 25 June 2021. The ex-dividend date is 10 June 2021. The record date for the dividend is 11 June 2021. This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English Law by virtue of the European (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via a Regulatory Information Service, this information is now considered to be in the public domain. For further information, please contact: John...

Continue reading

Proactive news headlines including Predictive Discovery, Nova Minerals, Creso Pharma and Strategic Elements

Sydney, June 03, 2021 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:Predictive Discovery Ltd (ASX:PDI) has extended NE Bankan prospect at depth with strong gold grades of up to 5 metres at 2.4 g/t from 245 metres in diamond drilling at the Bankan Gold Project in Guinea. Click here Nova Minerals Ltd (OTCMKTS:NVAAF) (ASX:NVA) (FRA:QM3) has welcomed a resource update from the Thompson Brothers Lithium Project in Canada through its majority- owned subsidiary Snow Lake Resources Ltd. Click here Creso Pharma Ltd (ASX:CPH) (FRA:1X8) has traded higher on news that target acquisition company Halucenex Life Sciences Inc is looking to capitalise on recent regulatory shifts in the Californian healthcare market with its psychedelic...

Continue reading

Telia Lietuva, AB presentation to investors at event ‘CEO Meets Investors’

On 3 June 2021, CEO of Telia Lietuva, Dan Strömberg, made a presentation to investors at Nasdaq Baltic organized event CEO Meets Investors 2021. ENCL. Telia Lietuva presentation to investors Darius Džiaugys,Head of Investor Relations,tel. +370 5 236 7878,e-mail: darius.dziaugys@telia.ltAttachmentTelia Lietuva presentation at CEO Meets Investor

Continue reading

Lapin Tulostieto Oy’s business was transferred to Talenom 

Talenom Plc, Press release, 3 June 2021 at 12:00 EEST Lapin Tulostieto Oy’s business was transferred to Talenom  Talenom Plc has on 1 June 2021 acquired Lapin Tulostieto Oy’s accounting firm operations in Tornio, Ylitornio and Kolari.  The net sales of the acquired business transferred to Talenom amount to about 0.5 million euros. In the short term, the business acquisition will not have any significant impact on Talenom’s financial position or future outlook. After the acquisition, the company’s personnel will continue their work in Talenom’s employ. “The acquisition of the business operations of Lapin Tulostieto Oy puts us in a better position to offer local accounting firm services in the western Lappi region. Modern financial management solutions have made it possible to provide accounting services regardless of location, however,...

Continue reading

Sodexo – Monthly disclosure on share capital and voting rights May 31, 2021

MONTHLY DISCLOSURE ON SHARE CAPITAL AND VOTING RIGHTS Pursuant to Article L.233-8-II of the French Commercial Code and Article 223-16 of the General Regulations of the Autorités des Marchés Financiers Issy-les-Moulineaux, June 3, 2021 Registered name of the issuer: SODEXO255, quai de la Bataille de Stalingrad – 92130 ISSY-LES-MOULINEAUXDate Total number of shares Actual voting rights * Theoretical voting rights **  May 31, 2021     147,454,887   215,624,279   216,775,691  *         Actual voting rights: all of the Company shares have the same voting rights, except for treasury shares which do not have voting rights and registered shares held for more than four years, which have double voting rights.**         Theoretical voting rights: the number of theoretical voting rights is calculated based on the shares having either single...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.